|
Market Closed -
Other stock markets
|
Pre-market 07:59:25 pm | |||
| 26.61 USD | -0.04% |
|
26.56 | -0.19% |
| 07:56pm | Top pharma companies racing to launch a weight-loss pill | RE |
| 07:16pm | Oil Shock Meets Job Shock |
| Capitalization | 15TCr 13TCr 12TCr 11TCr 21TCr 13,89600Cr 22TCr 1,40200Cr 56TCr 6,65800Cr 57TCr 56TCr 23,87300Cr | P/E ratio 2026 * |
12.4x | P/E ratio 2027 * | 13x |
|---|---|---|---|---|---|
| Enterprise value | 19TCr 17TCr 15TCr 15TCr 27TCr 17,76900Cr 28TCr 1,79300Cr 72TCr 8,51300Cr 73TCr 71TCr 30,52700Cr | EV / Sales 2026 * |
3.16x | EV / Sales 2027 * | 3.21x |
| Free-Float |
59.04% | Yield 2026 * |
6.61% | Yield 2027 * | 6.64% |
Last Transcript: Pfizer Inc.
| 1 day | -0.13% | ||
| 1 week | -1.81% | ||
| Current month | -3.76% | ||
| 1 month | +0.45% | ||
| 3 months | +2.23% | ||
| 6 months | +6.95% | ||
| Current year | +6.87% |
| 1 week | 26.2 | 27.61 | |
| 1 month | 26.2 | 27.94 | |
| Current year | 24.83 | 27.94 | |
| 1 year | 20.92 | 27.94 | |
| 3 years | 20.92 | 42.22 | |
| 5 years | 20.92 | 61.71 | |
| 10 years | 20.92 | 61.71 |
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 64 | 01/01/2019 |
David Denton
DFI | Director of Finance/CFO | 61 | 02/05/2022 |
| Chief Tech/Sci/R&D Officer | - | 24/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Suzanne Johnson
BRD | Director/Board Member | 68 | 01/09/2007 |
Shantanu Narayen
BRD | Director/Board Member | 62 | 27/09/2013 |
Albert Bourla
CHM | Chairman | 64 | 01/01/2020 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.04% | -1.81% | +2.58% | -35.33% | 15TCr | ||
| -2.02% | -3.79% | +5.76% | +208.78% | 88TCr | ||
| -2.31% | -1.58% | +45.12% | +55.58% | 58TCr | ||
| -1.63% | +3.41% | +9.84% | +48.89% | 41TCr | ||
| -3.34% | -7.41% | +12.26% | +25.53% | 36TCr | ||
| -1.73% | -6.41% | +20.93% | +35.41% | 30TCr | ||
| -2.27% | -6.44% | +22.75% | +54.13% | 30TCr | ||
| -3.50% | -2.71% | +24.55% | +8.60% | 29TCr | ||
| -3.08% | -3.09% | +16.12% | +56.55% | 20TCr | ||
| -2.08% | +0.95% | +25.73% | +79.03% | 18TCr | ||
| Average | -1.17% | -1.50% | +18.56% | +53.72% | 36.51TCr | |
| Weighted average by Cap. | -1.22% | -1.65% | +18.66% | +80.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.12TCr 5.29TCr 4.79TCr 4.6TCr 8.39TCr 5,61700Cr 8.76TCr 57TCr 23TCr 2,69100Cr 23TCr 22TCr 9,65000Cr | 5.89TCr 5.1TCr 4.61TCr 4.43TCr 8.08TCr 5,41200Cr 8.44TCr 55TCr 22TCr 2,59300Cr 22TCr 22TCr 9,29800Cr |
| Net income | 1.21TCr 1.04TCr 944.18Cr 906.48Cr 1.65TCr 1,10700Cr 1.73TCr 11TCr 4.46TCr 53TCr 4.53TCr 4.43TCr 1,90200Cr | 1.17TCr 1.01TCr 913.3Cr 876.83Cr 1.6TCr 1,07100Cr 1.67TCr 11TCr 4.32TCr 51TCr 4.38TCr 4.28TCr 1,84000Cr |
| Net Debt | 4.22TCr 3.65TCr 3.3TCr 3.17TCr 5.78TCr 3,87300Cr 6.04TCr 39TCr 16TCr 1,85600Cr 16TCr 15TCr 6,65500Cr | 3.8TCr 3.28TCr 2.97TCr 2.85TCr 5.2TCr 3,48500Cr 5.43TCr 35TCr 14TCr 1,67000Cr 14TCr 14TCr 5,98800Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/26/05 | 26.61 $ | -0.04% | 3,89,08,616 |
| 04/26/04 | 26.62 $ | +0.15% | 3,08,93,515 |
| 03/26/03 | 26.58 $ | -2.49% | 4,14,86,090 |
| 02/26/02 | 27.26 $ | -1.41% | 4,13,21,689 |
| 27/26/27 | 27.65 $ | +2.03% | 4,18,79,693 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- PFE Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition

















